Published: 29.10.2018
References:
- Barkanova O.V. (2009) Metodiki diagnostiki emotsionalnoy sferyi Psihologicheskiy praktikum. Litera-print, Krasnoyarsk, 237 s.
- Kamchatnov P.R., Chugunov A.V., Evzelman M.A. (2016) Porazhenie perifericheskoy nervnoy sistemyi pri saharnom diabete. myish. bol., 6(2): 20–26.
- Morozova O.G. (2009) Polineyropatii v somaticheskoy praktike. Nov. med. farmats., 20(300): 10–12.
- Pankiv V.I. (2013) Tsukrovyi diabet: vyznachennia, klasyfikatsiia, epidemiolohiia, faktory ryzyku. Mizhnar. nevrol. zhurn., 7(55): 95–104.
- Sakovets T.G., Bogdanov E.I. (2013) Bolevyie neyropatii: etiologiya, patogenez, klinicheskie proyavleniya. Akt. probl. med., 1–2(69): 96–100.
- Smulevich A.B. (2000) Depressii v obschemeditsinskoy praktike. Bereg, Moskva, 160 s.
- Argoff Ch.E., Cole B.E., Fishbain D.A., Irving G.A. (2006) Diabetic Peripheral Neuropathic Pain: Clinical and Quality-of-Life Issues. Mayo Clin. Proc., 81(4): 3–11.
- Davies M., Brophy S., Williams R., Taylor A. (2006) The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care, 29(7): 1518–1522.
- Gore M., Brandenburg N.A., Dukes E. et al. (2005) Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep. J. Pain Symptom Manage, 30(4): 374–385.
- Jamesson J.L., De Groot L.J. (2016) Endocrinology: Adult and Pediatric. 7th ed., Vol. 1. Elsevier, Amsterdam, 2704 p.
- Mallison R., Tilke C., Brasser M., Pittrow D. (2007) Efficacy and tolerability of pregabalin in patients with neuropathic pain. Observational study under clinical practice conditions. MMW Fortschr. Med., 149(14): 46.
- Sadosky A., Schaefer C., Mann R. et al. (2013) Burden of illness associated with painful diabetic peripheral neuropathy among adults seeking treatment in the US: results from a retrospective chart review and cross-sectional survey. Diabetes Metab. Syndr. Obes., 6: 79–92.
- Thomas P.K. (1999) Diabetic peripheral neuropathies: their cost to patient and society and the value of knowledge of risk factors for development of interventions. Eur. Neurol., 41(1): 35–43.
- WHO (2016) Global report on diabetes (http://www.who.int/diabetes/global-report/en/).